026 — Tirzepatide for Obesity, Ixchiq Chikungunya Vaccine, fruquintinib for mCRC, Adzynma (ADAMTS13, recombinant-krhn) for cTTP
Here is information on the latest US FDA approvals, the week of November 6 - November 10, 2023Tirzepatide (Zepbound) for Adults With ObesityThe FDA has approved Zepbound (tirzepatide) injection for…